Advanced Biomed (ADVB) Operating Leases (2024 - 2026)

Advanced Biomed has disclosed Operating Leases across 3 years of filings, most recently posting $10903.0 for Q1 2026.

• Operating Leases for Q1 2026 came in at $10903.0, down 75.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $10903.0 (down 75.48% YoY), and the FY2025 annual result was $5879.0, down 90.89% from the prior year.
• Operating Leases came in at $10903.0 for Q1 2026 at Advanced Biomed, up from $1431.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $64529.0 in Q2 2024 to a low of $1431.0 in Q4 2025.
• The 3-year median for Operating Leases is $10903.0 (2026), against an average of $26639.3.
• Across the five-year window, Operating Leases tumbled 97.46% in 2025 and plunged 75.48% in 2026, its largest moves.
• Advanced Biomed's Operating Leases stood at $56326.0 in 2024, then tumbled by 97.46% to $1431.0 in 2025, then jumped by 661.91% to $10903.0 in 2026.
• The last three Operating Leases figures came in at $10903.0 (Q1 2026), $1431.0 (Q4 2025), and $2935.0 (Q3 2025), per Business Quant data.